Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast

Circulation

Volumn 88, Issue 2, 1993, Pages 596-604

  Villanueva, Flordeliza S ^a   Glasheen, William P ^a   Sklenar, Jiri ^a   Kaul, Sanjiv ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Echocardiography; Infarcts; Occlusion; Reperfusion

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOACTIVE MICROSPHERE; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD FLOWMETRY; CONTRAST ENHANCEMENT; DOG; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMAL; AUTORADIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; DOBUTAMINE; DOGS; ECHOCARDIOGRAPHY; HEART ATRIUM; INJECTIONS; MICROSPHERES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TECHNETIUM TC 99M SESTAMIBI; TETRAZOLIUM SALTS;

EID: 0027170562     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.2.596     Document Type: Article

References (42)

1. Kloner RA, Ganote CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
2. Willerson JT, Watson JT, Templeton GH, Fixier DE. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res. 1975;36:771-781.
3. Krug A, deRochemont WM, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 1966;19:57-62.
4. West PN, Connors JP, Clark RE, Weldon CS, Ramsey DL, Roberts R, Sobel BE, Williamson JR. Compromised microvascular integrity in ischemic myocardium. Lab Invest. 1978;38:677-684.
5. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945-952.
6. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation. 1983;68(suppl I):I-8-I-15.
7. Johnson WB, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation. 1988;78:462-472.
8. Vanhaecke J, Flameng W, Borgers M, Jang K, Van de Werf F, De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res. 1990;67:1201-1210.
9. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res. 1989; 65:458-467.
10. Edwards N, Jayaweera AR, Glasheen WP, Brocoli A, Spotnitz WD, Kaul S. Myocardial contrast two-dimensional echocardiography can be used to measure myocardial red blood cell transit in-vivo. Circulation. 1990;82(suppl III):III-96. Abstract.
11. Villanueva FS, Glasheen WP, Sklenar J, Jayaweera AR, Kaul S. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right atrial injection of contrast. Circulation. 1992;85:1557-1564.
12. Jayaweera AR, Matthew TL, Sklenar J, Spotnitz WD, Watson DD, Kaul S. Method for the quantitation of myocardial perfusion during myocardial contrast two-dimensional echocardiography. J Am Soc Echocardiogr. 1990;3:91-98.
13. Kaul S, Jayaweera AR, Glasheen WP, Villanueva FS, Gutgessel HP, Spotnitz WD. Myocardial contrast echocardiography and the transmural distribution of flow: a critical appraisal during myocardial ischemia not associated with infarction. J Am Coll Cardiol. 1992;20:1005-1016.
14. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE. Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk." J Am Coll Cardiol. 1984;4:1272-1282.
15. DeBoer LW, Strauss HW, Kloner RA, Rude RE, Davis RF, Maroko PR, Braunwald E. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size after experimental coronary artery occlusion. Proc Natl Acad Sci U S A. 1980-77:6119-6123.
16. Kaul S, Glasheen W, Ruddy RD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast echocardiography. Circulation. 1987;75:1249-1260.
17. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593-600.
18. Heyman MA, Payne BD, Huffman JI, Rudolf AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:52-79.
19. Kaul S, Kelly P, Oliner JD, Glasheen WP, Keller MW, Watson DD. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol. 1989;13:468-482.
20. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death: II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-644.
21. Sakamaki T, Tei C, Meerbaum S, Shimoura K, Kondo S, Fishbein MC, Y-Rit J, Shah PM, Corday E. Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium. J Am Coll Cardiol. 1984;3:34-38.
22. Kemper AJ, O'Boyle JE, Sharma S, Cohen CA, Kloner R, Khuri SF, Parisi AF. Hydrogen peroxide contrast-enhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion. Circulation. 1983;68:603-611.
23. Kemper AJ, O'Boyle JE, Cohen CA, Taylor A, Parisi AF. Hydrogen peroxide contrast echocardiography: quantification in-vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation. 1984;70:309-317.
24. Gruppo Italiano per lo Studio della Streptochinasi nel' Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-401.
25. The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med. 1986;314:1465-1471.
26. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet. 1988;1:545-549.
27. Keller MW, Glasheen WP, Kaul S. Albunex®: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr. 1989;2:48-52.
28. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. The temporal profile of the 'no-reflow' phenomenon: a study using myocardial contrast echocardiography. Circulation. 1992;86(suppl I):I-521. Abstract.
29. Kaul SK, Villanueva FS. Is the determination of myocardial perfusion necessary to evaluate the success of reperfusion when the infarct-related artery is open? Circulation. 1992;85:1942-1944.
30. Ito H, Tomooka T, Sakai N, Hisahiro Y, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful coronary reflow: a predictor of poor recovery of left ventricular function in acute myocardial infarction. Circulation. 1992;85:1699-1705.
31. White FC, Sanders M, Bloor CM. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol. 1978;42:234-243.
32. Cobb FR, Bache RJ, Rivas F, Greenfield JC. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest. 1976;57:1359-1368.
33. Lim YJ, Nanto S, Masuyama T, Kodama K, Ikeda T, Kitabatake A, Kamada T. Visualization of subendocardial myocardial ischemia with myocardial contrast echocardiography in humans. Circulation. 1989;79:233-244.
34. Cheirif J, Zoghbi WA, Bolli R, O'Neill PG, Hoyt B, Quinones M. Assessment of regional myocardial perfusion by contrast echocardiography: II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis. J Am Coll Cardiol. 1989;14:1555-1565.
35. Wusten B. Biophysics of myocardial perfusion. In: Schaper W, ed. The Pathophysiology of Myocardial Perfusion. Amsterdam: Elsevier/ North Holland Biomedical Press; 1979:199-244.
36. Kaul S, Jayaweera AR. Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve. J Am Coll Cardiol. 1993;21:356-358.
37. Bolognese L, Sarasso G, Bongo AS, Aralda D, Piccinio C, Rossi L, Rossi P. Stress testing in the postinfarction period. Circulation. 1991;83(suppl III):III-32-III-37.
38. Rahonsky A, Kempthorne-Rawson J, Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation. 1990; 81:1205-1209.
39. Kaul S, Villanueva FS. Dipyridamole-thallium-201 imaging: How safe is it? When should it be used? J Nucl Med. 1991;32:2115-2117.
40. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole thallium-201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurring myocardial ischemic events. Am J Cardiol. 1990;65:160-167.
41. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
42. Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol. 1990;16:695-704.